Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.

Duss FR, Garcia de la Mària C, Croxatto A, Giulieri S, Lamoth F, Manuel O, Miró JM.

J Antimicrob Chemother. 2019 Jul 11. pii: dkz253. doi: 10.1093/jac/dkz253. [Epub ahead of print]

PMID:
31298264
2.

Diagnosis and treatment of invasive fungal infections: looking ahead.

Sanguinetti M, Posteraro B, Beigelman-Aubry C, Lamoth F, Dunet V, Slavin M, Richardson MD.

J Antimicrob Chemother. 2019 Mar 1;74(Supplement_2):ii27-ii37. doi: 10.1093/jac/dkz041.

PMID:
31222314
3.

Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside.

Aruanno M, Glampedakis E, Lamoth F.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00399-19. doi: 10.1128/AAC.00399-19. Print 2019 Aug. Review.

PMID:
31138565
4.

Link between Heat Shock Protein 90 and the Mitochondrial Respiratory Chain in the Caspofungin Stress Response of Aspergillus fumigatus.

Aruanno M, Bachmann D, Sanglard D, Lamoth F.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00208-19. doi: 10.1128/AAC.00208-19. Print 2019 Jul.

PMID:
31061164
5.

Isavuconazole brain penetration in cerebral aspergillosis.

Lamoth F, Mercier T, André P, Pagani JL, Pantet O, Maduri R, Guery B, Decosterd LA.

J Antimicrob Chemother. 2019 Jun 1;74(6):1751-1753. doi: 10.1093/jac/dkz050. No abstract available.

PMID:
30753519
6.

Diagnostic approach to encephalitis and meningoencephalitis in adult returning travellers.

Kenfak A, Eperon G, Schibler M, Lamoth F, Vargas MI, Stahl JP.

Clin Microbiol Infect. 2019 Apr;25(4):415-421. doi: 10.1016/j.cmi.2019.01.008. Epub 2019 Jan 29. Review.

PMID:
30708123
7.

Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.

Bassetti M, Scudeller L, Giacobbe DR, Lamoth F, Righi E, Zuccaro V, Grecchi C, Rebuffi C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot SI, Cornely OA, Lass-Flörl C, Koehler P, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Maertens J, Martin-Loeches I, Muñoz P, Kullberg BJ, Agvald-Ohman C, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Calandra T; from the Study Group for Infections in Critically Ill Patients (ESGCIP) and the Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID); European Society of Intensive Care Medicine (ESICM); European Confederation of Medical Mycology (ECMM); Mycoses Study Group Education and Research Consortium (MSGERC).

Mycoses. 2019 Apr;62(4):310-319. doi: 10.1111/myc.12869. Epub 2019 Jan 22.

PMID:
30426598
8.

Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.

Glampedakis E, Coste AT, Aruanno M, Bachmann D, Delarze E, Erard V, Lamoth F.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01137-18. doi: 10.1128/AAC.01137-18. Print 2018 Dec.

9.

Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections.

Burger R, Guidi M, Calpini V, Lamoth F, Decosterd L, Robatel C, Buclin T, Csajka C, Marchetti O.

J Antimicrob Chemother. 2018 Dec 1;73(12):3413-3422. doi: 10.1093/jac/dky370.

PMID:
30304491
10.

Let's add invasive aspergillosis to the list of influenza complications.

Lamoth F, Calandra T.

Lancet Respir Med. 2018 Oct;6(10):733-735. doi: 10.1016/S2213-2600(18)30332-1. Epub 2018 Jul 31. No abstract available.

PMID:
30076120
11.

Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).

Kritikos A, Neofytos D, Khanna N, Schreiber PW, Boggian K, Bille J, Schrenzel J, Mühlethaler K, Zbinden R, Bruderer T, Goldenberger D, Pfyffer G, Conen A, Van Delden C, Zimmerli S, Sanglard D, Bachmann D, Marchetti O, Lamoth F; Fungal Infection Network of Switzerland (FUNGINOS).

Clin Microbiol Infect. 2018 Nov;24(11):1214.e1-1214.e4. doi: 10.1016/j.cmi.2018.05.012. Epub 2018 Jun 15.

PMID:
29909005
12.

Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy.

Brunel AS, Wójtowicz A, Lamoth F, Spertini O, Neofytos D, Calandra T, Marchetti O, Bochud PY.

Haematologica. 2018 Nov;103(11):e527-e530. doi: 10.3324/haematol.2018.195453. Epub 2018 Jun 7. No abstract available.

13.

First case of Candida auris in Switzerland: discussion about preventive strategies.

Riat A, Neofytos D, Coste A, Harbarth S, Bizzini A, Grandbastien B, Pugin J, Lamoth F.

Swiss Med Wkly. 2018 Apr 26;148:w14622. doi: 10.4414/smw.2018.14622. eCollection 2018. No abstract available.

14.

Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.

Damonti L, Erard V, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Imhof A, Zbinden R, Fehr J, Boggian K, Bruderer T, Flückiger U, Frei R, Orasch C, Conen A, Khanna N, Bregenzer T, Bille J, Lamoth F, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Intensive Care Med. 2018 Mar;44(3):405-407. doi: 10.1007/s00134-018-5081-4.

PMID:
29464298
15.

Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.

Couchepin J, Brunel AS, Jaton K, Meylan P, Bochud PY, Lamoth F.

Mycoses. 2018 Jun;61(6):350-354. doi: 10.1111/myc.12755. Epub 2018 Mar 14.

PMID:
29453853
16.

The Candida auris Alert: Facts and Perspectives.

Lamoth F, Kontoyiannis DP.

J Infect Dis. 2018 Jan 30;217(4):516-520. doi: 10.1093/infdis/jix597. Review. No abstract available.

PMID:
29390110
17.

Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study.

Orasch C, Mertz D, Garbino J, van Delden C, Emonet S, Schrenzel J, Zimmerli S, Damonti L, Mühlethaler K, Imhof A, Ruef C, Fehr J, Zbinden R, Boggian K, Bruderer T, Flückiger U, Conen A, Khanna N, Frei R, Bregenzer T, Lamoth F, Erard V, Bochud PY, Calandra T, Bille J, Marchetti O; Fungal Infection Network of Switzerland (FUNGINOS).

J Infect. 2018 May;76(5):489-495. doi: 10.1016/j.jinf.2017.12.018. Epub 2018 Jan 31.

PMID:
29378240
18.

Changes in the epidemiological landscape of invasive candidiasis.

Lamoth F, Lockhart SR, Berkow EL, Calandra T.

J Antimicrob Chemother. 2018 Jan 1;73(suppl_1):i4-i13. doi: 10.1093/jac/dkx444. Review.

PMID:
29304207
19.

Early diagnosis of invasive mould infections and disease.

Lamoth F, Calandra T.

J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i19-i28. doi: 10.1093/jac/dkx030. Review.

PMID:
28355464
20.

Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.

Damonti L, Erard V, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Imhof A, Zbinden R, Fehr J, Boggian K, Bruderer T, Flückiger U, Frei R, Orasch C, Conen A, Khanna N, Bregenzer T, Bille J, Lamoth F, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Intensive Care Med. 2017 Jun;43(6):935-939. doi: 10.1007/s00134-017-4737-9. Epub 2017 Mar 7. No abstract available. Erratum in: Intensive Care Med. 2018 Feb 20;:.

PMID:
28271318
21.

Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.

Lamoth F, Chung SJ, Damonti L, Alexander BD.

Clin Infect Dis. 2017 Jun 1;64(11):1619-1621. doi: 10.1093/cid/cix130. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

PMID:
28199491
22.

Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis.

Lamoth F.

J Fungi (Basel). 2016 Jul 4;2(3). pii: E22. doi: 10.3390/jof2030022. Review.

23.

Aspergillus fumigatus-Related Species in Clinical Practice.

Lamoth F.

Front Microbiol. 2016 May 17;7:683. doi: 10.3389/fmicb.2016.00683. eCollection 2016. Review.

24.

Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections.

Lamoth F, Damonti L, Alexander BD.

J Clin Microbiol. 2016 Jun;54(6):1638-1640. doi: 10.1128/JCM.00318-16. Epub 2016 Mar 23.

25.

Editorial: Advances in Aspergillus fumigatus Pathobiology.

Lamoth F, Juvvadi PR, Steinbach WJ.

Front Microbiol. 2016 Feb 3;7:43. doi: 10.3389/fmicb.2016.00043. eCollection 2016. No abstract available.

26.

Potential Microbiological Effects of Higher Dosing of Echinocandins.

Steinbach WJ, Lamoth F, Juvvadi PR.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S669-77. doi: 10.1093/cid/civ725.

PMID:
26567286
27.

Waddlia: An emerging pathogen and a model organism to study the biology of chlamydiae.

Lamoth F, Pillonel T, Greub G.

Microbes Infect. 2015 Nov-Dec;17(11-12):732-7. doi: 10.1016/j.micinf.2015.09.021. Epub 2015 Sep 30.

PMID:
26432516
28.

Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds.

Lamoth F, Alexander BD.

J Clin Microbiol. 2015 Oct;53(10):3176-81. doi: 10.1128/JCM.00925-15. Epub 2015 Jul 22.

29.

Calcium-Mediated Induction of Paradoxical Growth following Caspofungin Treatment Is Associated with Calcineurin Activation and Phosphorylation in Aspergillus fumigatus.

Juvvadi PR, Muñoz A, Lamoth F, Soderblom EJ, Moseley MA, Read ND, Steinbach WJ.

Antimicrob Agents Chemother. 2015 Aug;59(8):4946-55. doi: 10.1128/AAC.00263-15. Epub 2015 Jun 8.

30.

The Aspergillus fumigatus septins play pleiotropic roles in septation, conidiation, and cell wall stress, but are dispensable for virulence.

Vargas-Muñiz JM, Renshaw H, Richards AD, Lamoth F, Soderblom EJ, Moseley MA, Juvvadi PR, Steinbach WJ.

Fungal Genet Biol. 2015 Aug;81:41-51. doi: 10.1016/j.fgb.2015.05.014. Epub 2015 Jun 5.

31.

Hsp70 and the Cochaperone StiA (Hop) Orchestrate Hsp90-Mediated Caspofungin Tolerance in Aspergillus fumigatus.

Lamoth F, Juvvadi PR, Soderblom EJ, Moseley MA, Steinbach WJ.

Antimicrob Agents Chemother. 2015 Aug;59(8):4727-33. doi: 10.1128/AAC.00946-15. Epub 2015 May 26.

32.

Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.

Lamoth F, Alexander BD.

Antimicrob Agents Chemother. 2015 Jul;59(7):4308-11. doi: 10.1128/AAC.00234-15. Epub 2015 Apr 20.

33.

Identification and mutational analyses of phosphorylation sites of the calcineurin-binding protein CbpA and the identification of domains required for calcineurin binding in Aspergillus fumigatus.

Juvvadi PR, Ma Y, Richards AD, Soderblom EJ, Moseley MA, Lamoth F, Steinbach WJ.

Front Microbiol. 2015 Mar 13;6:175. doi: 10.3389/fmicb.2015.00175. eCollection 2015.

34.

Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis.

Lamoth F, Juvvadi PR, Steinbach WJ.

Front Microbiol. 2015 Feb 16;6:96. doi: 10.3389/fmicb.2015.00096. eCollection 2015.

35.

Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species.

Lamoth F, Alexander BD, Juvvadi PR, Steinbach WJ.

J Antimicrob Chemother. 2015 May;70(5):1408-11. doi: 10.1093/jac/dku549. Epub 2015 Jan 3.

PMID:
25558076
36.

[Diagnostic approach of intracellular bacteria and fastidious microorganisms].

Lamoth F, Schrenzel J, Greub G.

Rev Med Suisse. 2014 Nov 12;10(450):2130-6. French.

PMID:
25549373
38.

Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.

Lamoth F, Juvvadi PR, Steinbach WJ.

Crit Rev Microbiol. 2016;42(2):310-21. doi: 10.3109/1040841X.2014.947239. Epub 2014 Sep 22. Review.

PMID:
25243616
39.

Calcineurin-mediated regulation of hyphal growth, septation, and virulence in Aspergillus fumigatus.

Juvvadi PR, Lamoth F, Steinbach WJ.

Mycopathologia. 2014 Dec;178(5-6):341-8. doi: 10.1007/s11046-014-9794-9. Epub 2014 Aug 15. Review.

40.

Nonmolecular methods for the diagnosis of respiratory fungal infections.

Lamoth F, Alexander BD.

Clin Lab Med. 2014 Jun;34(2):315-36. doi: 10.1016/j.cll.2014.02.006. Epub 2014 Apr 12. Review.

PMID:
24856530
41.

Polymorphisms in tumor necrosis factor-α increase susceptibility to intra-abdominal Candida infection in high-risk surgical ICU patients*.

Wójtowicz A, Tissot F, Lamoth F, Orasch C, Eggimann P, Siegemund M, Zimmerli S, Flueckiger UM, Bille J, Calandra T, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Crit Care Med. 2014 Apr;42(4):e304-8. doi: 10.1097/CCM.0000000000000208.

PMID:
24557424
42.

Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus.

Lamoth F, Juvvadi PR, Soderblom EJ, Moseley MA, Asfaw YG, Steinbach WJ.

Antimicrob Agents Chemother. 2014;58(4):1889-96. doi: 10.1128/AAC.02286-13. Epub 2014 Jan 6.

43.

Transcriptional activation of heat shock protein 90 mediated via a proximal promoter region as trigger of caspofungin resistance in Aspergillus fumigatus.

Lamoth F, Juvvadi PR, Gehrke C, Asfaw YG, Steinbach WJ.

J Infect Dis. 2014 Feb 1;209(3):473-81. doi: 10.1093/infdis/jit530. Epub 2013 Oct 4.

44.

Phosphorylation of Calcineurin at a novel serine-proline rich region orchestrates hyphal growth and virulence in Aspergillus fumigatus.

Juvvadi PR, Gehrke C, Fortwendel JR, Lamoth F, Soderblom EJ, Cook EC, Hast MA, Asfaw YG, Moseley MA, Creamer TP, Steinbach WJ.

PLoS Pathog. 2013;9(8):e1003564. doi: 10.1371/journal.ppat.1003564. Epub 2013 Aug 22.

45.

β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.

Tissot F, Lamoth F, Hauser PM, Orasch C, Flückiger U, Siegemund M, Zimmerli S, Calandra T, Bille J, Eggimann P, Marchetti O; Fungal Infection Network of Switzerland (FUNGINOS).

Am J Respir Crit Care Med. 2013 Nov 1;188(9):1100-9. doi: 10.1164/rccm.201211-2069OC.

PMID:
23782027
46.

In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains.

Lamoth F, Juvvadi PR, Gehrke C, Steinbach WJ.

Antimicrob Agents Chemother. 2013 Feb;57(2):1035-9. doi: 10.1128/AAC.01857-12. Epub 2012 Nov 19.

47.

Heat shock protein 90 is required for conidiation and cell wall integrity in Aspergillus fumigatus.

Lamoth F, Juvvadi PR, Fortwendel JR, Steinbach WJ.

Eukaryot Cell. 2012 Nov;11(11):1324-32. doi: 10.1128/EC.00032-12. Epub 2012 Jul 20.

48.

β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).

Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O; Third European Conference on Infections in Leukemia (ECIL-3).

Clin Infect Dis. 2012 Mar 1;54(5):633-43. doi: 10.1093/cid/cir897. Epub 2011 Dec 23. Review.

PMID:
22198786
49.

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.

Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S; European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups.

Bone Marrow Transplant. 2012 Jun;47(6):846-54. doi: 10.1038/bmt.2011.178. Epub 2011 Sep 19. Review.

PMID:
21927034
50.

Parachlamydia and Rhabdochlamydia: emerging agents of community-acquired respiratory infections in children.

Lamoth F, Jaton K, Vaudaux B, Greub G.

Clin Infect Dis. 2011 Sep;53(5):500-1. doi: 10.1093/cid/cir420. Epub 2011 Aug 2. No abstract available.

Supplemental Content

Loading ...
Support Center